Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13046-023-02720-2.

Title:
Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer | Journal of Experimental & Clinical Cancer Research
Description:
Introduction Cuproptosis and ferroptosis are the two newly defined metal-related regulated cell death. However, the crosstalk between cuproptosis and ferroptosis is obscure. Materials and methods We analyzed the effect of ferroptosis inducers on copper ionophores-induced cell death through CCK-8 assay. Cuproptosis was studied using immunofluorescence and protein soluble-insoluble fraction isolation. GSH assay, qRT-PCR and western blot were adopted to explore the machinery of ferroptosis inducers enhanced cuproptosis. And mouse xenograft model was built to detect the synergy effect of elesclomol-Cu and sorafenib in vivo. Results Herein we found that ferroptosis inducers sorafenib and erastin could enhance cuproptosis in primary liver cancer cells by increasing copper dependent lipoylated protein aggregation. Mechanically, sorafenib and erastin upregulated protein lipoylation via suppressing mitochondrial matrix-related proteases mediated ferredoxin 1 (FDX1) protein degradation, and reduced intracellular copper chelator glutathione (GSH) synthesis through inhibiting cystine importing. Discussion/Conclusion Our findings proposed that combination of ferroptosis inducers and copper ionophores to co-targeting ferroptosis and cuproptosis could be a novel therapeutic strategy for primary liver cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,603,474 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

cancer, ferroptosis, cell, cells, cuproptosis, protein, pubmed, copper, article, liver, fdx, sorafenib, gsh, inducers, google, scholar, death, erastin, fig, mhcc, dlat, cas, intracellular, level, sora, lipoylation, treatment, central, elesclomol, enhanced, mitochondrial, promoted, elesclomolcu, era, assay, fins, sense, antisense, wang, induced, aggregation, ion, metal, qbc, treated, regulated, cck, results, full, effect,

Topics {✒️}

mitochondrial matrix-related proteases quantitative real-time pcr copper-induced cell death inducing iron-dependent ferroptosis disulfiram/copper-induced ferroptosis arf6-driven endocytic recycling real-time rt-pcr cuproptosis-related gene signatures cuproptosis-related gene signature fins-increased elesclomol-cu cytotoxicity enzyme-engineered nonporous copper article download pdf established iron-dependent ferroptosis laboratory-animal research center 100u/ml penicillin–streptomycin rapid freeze-thaw method regulated cell death mitochondrial matrix proteases suppressing mitochondrial proteases anti-hepatocellular carcinoma effect elevated elesclomol-cu incubation triggered cell death promoted copper ionophores copper-induced cytotoxicity promote cell death nonapoptotic cell death ferroptotic cell death cell death dis newly identified modes regulated cell deaths subsequent cuproptosis enhanced suppressing intracellular glutathione 10µm sora + 10mm gsh primary liver cancer induce cell death stabilized fdx1 enhanced study included l-glutathione 10µm era + 10nm es lifeng feng designed 10µm sora + 10nm es upregulate protein lipoylation reduced copper ion privacy choices/manage cookies 06 mg/kg cucl2 typical ferroptosis inducers lipoylation-related proteins iron-dependent form full access liable copper ion mediated antioxidant reaction

Questions {❓}

  • Understanding Metal Dynamics between Cancer cells and macrophages: competition or synergism?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer
         description:Cuproptosis and ferroptosis are the two newly defined metal-related regulated cell death. However, the crosstalk between cuproptosis and ferroptosis is obscure. We analyzed the effect of ferroptosis inducers on copper ionophores-induced cell death through CCK-8 assay. Cuproptosis was studied using immunofluorescence and protein soluble-insoluble fraction isolation. GSH assay, qRT-PCR and western blot were adopted to explore the machinery of ferroptosis inducers enhanced cuproptosis. And mouse xenograft model was built to detect the synergy effect of elesclomol-Cu and sorafenib in vivo. Herein we found that ferroptosis inducers sorafenib and erastin could enhance cuproptosis in primary liver cancer cells by increasing copper dependent lipoylated protein aggregation. Mechanically, sorafenib and erastin upregulated protein lipoylation via suppressing mitochondrial matrix-related proteases mediated ferredoxin 1 (FDX1) protein degradation, and reduced intracellular copper chelator glutathione (GSH) synthesis through inhibiting cystine importing. Our findings proposed that combination of ferroptosis inducers and copper ionophores to co-targeting ferroptosis and cuproptosis could be a novel therapeutic strategy for primary liver cancer.
         datePublished:2023-06-06T00:00:00Z
         dateModified:2023-06-06T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-023-02720-2
         keywords:
            Cuproptosis
            Ferroptosis
            Copper ionophores
            Lipoylation
            Ferredoxin 1 (FDX1)
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig6_HTML.png
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:42
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Weikai Wang
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaizhong Lu
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Jiang
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qi Wei
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liyuan Zhu
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xian Wang
               affiliation:
                     name:Zhejiang University
                     address:
                        name:Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hongchuan Jin
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Lifeng Feng
               url:http://orcid.org/0000-0003-4506-1213
               affiliation:
                     name:Cancer Center of Zhejiang University, Zhejiang University
                     address:
                        name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer
      description:Cuproptosis and ferroptosis are the two newly defined metal-related regulated cell death. However, the crosstalk between cuproptosis and ferroptosis is obscure. We analyzed the effect of ferroptosis inducers on copper ionophores-induced cell death through CCK-8 assay. Cuproptosis was studied using immunofluorescence and protein soluble-insoluble fraction isolation. GSH assay, qRT-PCR and western blot were adopted to explore the machinery of ferroptosis inducers enhanced cuproptosis. And mouse xenograft model was built to detect the synergy effect of elesclomol-Cu and sorafenib in vivo. Herein we found that ferroptosis inducers sorafenib and erastin could enhance cuproptosis in primary liver cancer cells by increasing copper dependent lipoylated protein aggregation. Mechanically, sorafenib and erastin upregulated protein lipoylation via suppressing mitochondrial matrix-related proteases mediated ferredoxin 1 (FDX1) protein degradation, and reduced intracellular copper chelator glutathione (GSH) synthesis through inhibiting cystine importing. Our findings proposed that combination of ferroptosis inducers and copper ionophores to co-targeting ferroptosis and cuproptosis could be a novel therapeutic strategy for primary liver cancer.
      datePublished:2023-06-06T00:00:00Z
      dateModified:2023-06-06T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-023-02720-2
      keywords:
         Cuproptosis
         Ferroptosis
         Copper ionophores
         Lipoylation
         Ferredoxin 1 (FDX1)
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-023-02720-2/MediaObjects/13046_2023_2720_Fig6_HTML.png
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:42
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Weikai Wang
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaizhong Lu
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Jiang
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qi Wei
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liyuan Zhu
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xian Wang
            affiliation:
                  name:Zhejiang University
                  address:
                     name:Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hongchuan Jin
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Lifeng Feng
            url:http://orcid.org/0000-0003-4506-1213
            affiliation:
                  name:Cancer Center of Zhejiang University, Zhejiang University
                  address:
                     name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:42
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Cancer Center of Zhejiang University, Zhejiang University
      address:
         name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Weikai Wang
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Kaizhong Lu
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xin Jiang
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Qi Wei
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Liyuan Zhu
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xian Wang
      affiliation:
            name:Zhejiang University
            address:
               name:Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Hongchuan Jin
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Lifeng Feng
      url:http://orcid.org/0000-0003-4506-1213
      affiliation:
            name:Cancer Center of Zhejiang University, Zhejiang University
            address:
               name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
      name:Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China
      name:Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center of Zhejiang University, Zhejiang University, Hangzhou, China

External Links {🔗}(161)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.01s.